Arrowhead Acquires Novartis’ RNAi Research and Development Portfolio
Go back to Arrowhead Acquires Novartis’ RNAi Research and Development Portfolio| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 71.25 +2.46 (3.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.79 | 52 Week High | $8.22 | |||
| Open | $68.85 | 52 Week Low | $3.07 | |||
| Day High | $71.68 | P/E | N/A | |||
| Day Low | $68.08 | EPS | $-1.30 | |||
| Volume | 594,805 | |||||

